Status:
COMPLETED
Exploratory Study for the Validity of QuQu Scale
Lead Sponsor:
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Collaborating Sponsors:
Daiichi Sankyo Co., Ltd.
Conditions:
Alzheimer Dementia
Eligibility:
All Genders
Brief Summary
Examine the construct validity, the group discriminant ability, and the inter-rater reliability of a novel dementia rating scale (QuQu scale: QUick QUestion scale) candidate for the evaluation of pati...
Eligibility Criteria
Inclusion
- Alzheimer Dementia (AD) patients and patients with cognitive concern without dementia
- Written Informed consent by each subject and/or a legal representative, and study informant. If the doctor decides that the patient has no trouble in understanding this study, the written informed consent of a legal representative may be exempted. If not, this study needs a written informed consent by a legal representative and the patient except the case where the consent is hardly obtained due to the progression of the disease.
Exclusion
- patients with other types of dementia (e.g. vascular dementia, Levy body dementia, frontotemporal dementia)
- patients with other diseases which cause secondary dementia prior to Alzheimer Dementia (AD)
- patients with other severe neurological disease or psychiatric disorder without Alzheimer Dementia (AD)
- patients with other medical conditions where the investigators determine that it is inappropriate for the subject of this study (e.g. inappropriate for the evaluation of dementia rating scale)
Key Trial Info
Start Date :
October 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
972 Patients enrolled
Trial Details
Trial ID
NCT02267486
Start Date
October 1 2014
Last Update
July 15 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kagawa University School of Medicine
Kida-gun, Kagawa-ken, Japan, 761-0793